Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era - Scorecard - MDSpire

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era

  • By

  • Fabian Bartsch

  • Constantin Scholz

  • Lisa-Katharina Gröger

  • Lara Bachmann

  • Janine Baumgart

  • Ann-Kathrin Lederer

  • Jens Mittler

  • Maria Hoppe-Lotichius

  • Beate K. Straub

  • Friedrich Foerster

  • Arndt Weinmann

  • Evangelos Tagkalos

  • Hauke Lang

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Long-term Outcomes Following Surgical Resection of Intrahepatic Cholangiocarcinoma: Insights from the BILCAP Era and Beyond

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingSingle-center cohort study in Germany focusing on surgical resection outcomes.

Key Highlights

  • overall_survival

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • F
      • o
      • l
      • l
      • o
      • w
      • -
      • u
      • p
      • s
      • h
      • o
      • u
      • l
      • d
      • i
      • n
      • c
      • l
      • u
      • d
      • e
      • i
      • m
      • a
      • g
      • i
      • n
      • g
      • e
      • v
      • e
      • r
      • y
      • s
      • i
      • x
      • m
      • o
      • n
      • t
      • h
      • s
      • a
      • n
      • d
      • r
      • e
      • g
      • u
      • l
      • a
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • o
      • f
      • t
      • u
      • m
      • o
      • r
      • m
      • a
      • r
      • k
      • e
      • r
      • s
      • ,
      • w
      • i
      • t
      • h
      • s
      • p
      • e
      • c
      • i
      • f
      • i
      • c
      • m
      • e
      • n
      • t
      • i
      • o
      • n
      • o
      • f
      • C
      • T
      • o
      • r
      • M
      • R
      • I
      • .

      Risks

        Patient & Prescribing Data

        Adjuvant capecitabine therapy is recommended, although its impact on overall survival remains inconclusive; further studies are needed.

        Clinical Best Practices

        • recommendations

        Related Resources & Content

        Original Source(s)

        Related Content